Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075852 · ClinicalTrials.gov registry record
Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope
A clinical trial, sponsored by Mid Atlantic Retina.
- Completed
- Registry status
- 50
- Enrollment target
NCT03075852: Completed study, sponsored by Mid Atlantic Retina.
NCT03075852 is a clinical trial that has completed, run by Mid Atlantic Retina. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03075852 has completed, sponsored by Mid Atlantic Retina.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Prospective, cross-sectional, observational study investigating a three dimensional heads up display for retinal surgery and comparing its outcomes and ease of use with the standard operative microscope.
Primary Outcome
Intraoperative complications including: increased surgical time, needing to switch to standard operating microscope, increased time for ILM/ ELM peeling
Interventions
- DEVICE Heads- Up Display Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-05-26 |
| Est. Completion | 2018-08-08 |
What the finished NCT03075852 record still lists
NCT03075852 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Heads- Up Display Surgery is the first listed.
NCT03075852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03075852 about?
NCT03075852 is a clinical study titled "Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope". Prospective, cross-sectional, observational study investigating a three dimensional heads up display for retinal surgery and comparing its outcomes and ease of use with the standard operative microscope.
What is the current status of trial NCT03075852?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-05-26. Estimated completion is 2018-08-08.
What interventions are being tested in trial NCT03075852?
The interventions under investigation include: Heads- Up Display Surgery (DEVICE).
Who is sponsoring clinical trial NCT03075852?
This trial is sponsored by Mid Atlantic Retina, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI